These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 36578892)
1. Glycaemic Changes Among Children and Adolescents With Type 1 Diabetes Mellitus Before and During Ramadan Fasting Using Continuous Glucose Monitoring. Teoh ST; Hussain S; Hong JYH J ASEAN Fed Endocr Soc; 2022; 37(2):49-59. PubMed ID: 36578892 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting. Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467 [TBL] [Abstract][Full Text] [Related]
3. Ramadan Fasting Among Older Children and Adolescents With Type 1 Diabetes Mellitus: A Real-World Study From the UAE. Muammar T; Fojas EGF; Helal R; Lessan N Front Nutr; 2022; 9():786678. PubMed ID: 35399686 [TBL] [Abstract][Full Text] [Related]
4. Correlation between pre-ramadan glycemic control and subsequent glucose fluctuation during fasting in adolescents with Type 1 diabetes. Afandi B; Kaplan W; Al Hassani N; Hadi S; Mohamed A J Endocrinol Invest; 2017 Jul; 40(7):741-744. PubMed ID: 28239763 [TBL] [Abstract][Full Text] [Related]
5. Comparison of continuous glucose monitoring in adolescents with type 1 diabetes: Ramadan versus non-Ramadan. Kaplan W; Afandi B; Al Hassani N; Hadi S; Zoubeidi T Diabetes Res Clin Pract; 2017 Dec; 134():178-182. PubMed ID: 29061323 [TBL] [Abstract][Full Text] [Related]
6. Glucose excursions and glycaemic control during Ramadan fasting in diabetic patients: insights from continuous glucose monitoring (CGM). Lessan N; Hannoun Z; Hasan H; Barakat MT Diabetes Metab; 2015 Feb; 41(1):28-36. PubMed ID: 25497966 [TBL] [Abstract][Full Text] [Related]
7. Fasting during the holy month of Ramadan among older children and adolescents with type 1 diabetes in Kuwait. Mohamed K; Al-Abdulrazzaq D; Fayed A; El Busairi E; Al Shawaf F; Abdul-Rasoul M; Shaltout AA J Pediatr Endocrinol Metab; 2019 Aug; 32(8):843-849. PubMed ID: 31318694 [TBL] [Abstract][Full Text] [Related]
8. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation. Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827 [TBL] [Abstract][Full Text] [Related]
9. Initial increase in glucose variability during Ramadan fasting in non-insulin-treated patients with diabetes type 2 using continuous glucose monitoring. Aldawi N; Darwiche G; Abusnana S; Elbagir M; Elgzyri T Libyan J Med; 2019 Dec; 14(1):1535747. PubMed ID: 30348064 [TBL] [Abstract][Full Text] [Related]
10. A Real-World Prospective Study of the Effectiveness and Safety of Automated Insulin Delivery Compared With Other Modalities of Type 1 Diabetes Treatment During Ramadan Intermittent Fasting. Al-Sofiani ME; Alharthi S; Albunyan S; Alzaman N; Klonoff DC; Alguwaihes A Diabetes Care; 2024 Apr; 47(4):683-691. PubMed ID: 38290134 [TBL] [Abstract][Full Text] [Related]
11. The value of Continuous Glucose Monitoring and Self-Monitoring of Blood Glucose in patients with Gestational Diabetes Mellitus during Ramadan fasting. Afandi B; Hassanein M; Roubi S; Nagelkerke N Diabetes Res Clin Pract; 2019 May; 151():260-264. PubMed ID: 30822494 [TBL] [Abstract][Full Text] [Related]
12. Flash glucose monitoring system may benefit children and adolescents with type 1 diabetes during fasting at Ramadan. Al-Agha AE; Kafi SE; Zain Aldeen AM; Khadwardi RH Saudi Med J; 2017 Apr; 38(4):366-371. PubMed ID: 28397942 [TBL] [Abstract][Full Text] [Related]
13. Diabetes technology and treatments in the paediatric age group. Shalitin S; Peter Chase H Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816 [TBL] [Abstract][Full Text] [Related]
14. Optimizing type 1 diabetes after multiple daily injections and capillary blood monitoring: Pump or sensor first? A meta-analysis using pooled differences in outcome measures. Thomas MG; Avari P; Godsland IF; Lett AM; Reddy M; Oliver N Diabetes Obes Metab; 2021 Nov; 23(11):2521-2528. PubMed ID: 34286892 [TBL] [Abstract][Full Text] [Related]
15. Glycemic control during Ramadan fasting in adolescents and young adults with type 1 diabetes on MiniMed™ 780G advanced hybrid closed‑loop system: A randomized controlled trial. Elbarbary NS; Ismail EAR Diabetes Res Clin Pract; 2022 Sep; 191():110045. PubMed ID: 35987309 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of the low-glucose suspend feature of insulin pump during fasting during Ramadan in type 1 diabetes mellitus. Elbarbary NS Diabetes Metab Res Rev; 2016 Sep; 32(6):623-33. PubMed ID: 26789012 [TBL] [Abstract][Full Text] [Related]
17. The effect of Ramadan fasting on glycaemic control in insulin dependent diabetic patients: A literature review. Alabbood MH; Ho KW; Simons MR Diabetes Metab Syndr; 2017; 11(1):83-87. PubMed ID: 27402028 [TBL] [Abstract][Full Text] [Related]
18. Patients' and caregivers' experiences of using continuous glucose monitoring to support diabetes self-management: qualitative study. Lawton J; Blackburn M; Allen J; Campbell F; Elleri D; Leelarathna L; Rankin D; Tauschmann M; Thabit H; Hovorka R BMC Endocr Disord; 2018 Feb; 18(1):12. PubMed ID: 29458348 [TBL] [Abstract][Full Text] [Related]
19. Intermittent Fasting Could Be Safely Achieved in People With Type 1 Diabetes Undergoing Structured Education and Advanced Glucose Monitoring. Al-Ozairi E; El Samad A; Al Kandari J; Aldibbiat AM Front Endocrinol (Lausanne); 2019; 10():849. PubMed ID: 31866948 [No Abstract] [Full Text] [Related]
20. The use of Free Style Libre Continues Glucose Monitoring (FSL-CGM) to monitor the impact of Ramadan fasting on glycemic changes and kidney function in high-risk patients with diabetes and chronic kidney disease stage 3 under optimal diabetes care. Alawadi F; Rashid F; Bashier A; Abdelgadir E; Al Saeed M; Abuelkheir S; Khalifa A; Al Sayyah F; Bachet F; Elsayed M; Abdallah K; Hassanein M Diabetes Res Clin Pract; 2019 May; 151():305-312. PubMed ID: 30880094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]